Whilst personal possession is not straightforwardly criminalised, its supply and sale are regulated under the Human Medicines Regulations 2012, and use without clinical oversight falls entirely outside regulated UK healthcare
Talasaz A, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom J, Siegal D, Monreal M, Jimenez D, Vaduganathan M, Castellucci L, Cuker A, Barnes G, Connors J, Secemsky E, Van Tassell B, De Caterina R, Kurlander J, Aminian A, Piazza G, Goldhaber S, Moores L, Middeldorp S, Kirtane A, Elkind M, Angiolillo D, Konstantinides S, Lip G, Stone G, Cushman M, Krumholz H , Mehran R, Bhatt D, Bikdeli B
Glucagon measured by immunoassay Briefly, samples were incubated with two manufacturer-supplied anti-glucagon monoclonal antibodies that were covalently linked to either SmBiT or LgBiT
BMJ Evidence-Based Medicine 28(4):213-217
Semaglutide and tirzepatide are available now, while retatrutide remains in trials, so the practical comparison for most patients today is between the two approved options
These symptoms are usually most pronounced when starting the medication or increasing the dose, and they often improve over time
